| Literature DB >> 34561471 |
Patrick Reteng1, Linh Nguyen Thuy2, Tam Tran Thi Minh2, Maria Angélica Monteiro de Mello Mares-Guia3, Maria Celeste Torres3, Ana Maria Bispo de Filippis3, Yasuko Orba4, Shintaro Kobayashi5, Kyoko Hayashida1,6, Hirofumi Sawa4,6,7, William W Hall6,7,8,9, Lan Anh Nguyen Thi2, Junya Yamagishi10,11.
Abstract
Nucleic acid test (NAT), most typically quantitative PCR, is one of the standard methods for species specific flavivirus diagnosis. Semi-comprehensive NATs such as pan-flavivirus PCR which covers genus Flavivirus are also available; however, further specification by sequencing is required for species level differentiation. In this study, a semi-comprehensive detection system that allows species differentiation of flaviviruses was developed by integration of the pan-flavivirus PCR and Nanopore sequencing. In addition, a multiplexing method was established by adding index sequences through the PCR with a streamlined bioinformatics pipeline. This enables defining cut-off values for observed read counts. In the laboratory setting, this approach allowed the detection of up to nine different flaviviruses. Using clinical samples collected in Vietnam and Brazil, seven different flaviviruses were also detected. When compared to a commercial NAT, the sensitivity and specificity of our system were 66.7% and 95.4%, respectively. Conversely, when compared to our system, the sensitivity and specificity of the commercial NAT were 57.1% and 96.9%, respectively. In addition, Nanopore sequencing detected more positive samples (n = 8) compared to the commercial NAT (n = 6). Collectively, our study has established a semi-comprehensive sequencing-based diagnostic system for the detection of flaviviruses at extremely affordable costs, considerable sensitivity, and only requires simple experimental methods.Entities:
Mesh:
Year: 2021 PMID: 34561471 PMCID: PMC8463598 DOI: 10.1038/s41598-021-98013-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Sensitivity of PCR using the modified pan-flavivirus primers. (A) Fetal bovine serum were spiked with DENV1, DENV2, and YFV viral particles. RNAs were extracted from them then used as PCR template. (B) Plasmids containing the indicated sequences were used. Images were cropped from the original. Original image can be found in Supplementary Fig. S3 and S4. DENV Dengue Virus, JEV Japanese Encephalitis Virus, ZIKV Zika Virus, YFV Yellow Fever Virus, WNV West Nile Virus, TBEV Tick Borne Encephalitis Virus.
Details of the reads obtained from validation of the system using spiked sample and the optimized pipeline.
| Virus in the sample | MinION | Flongle 1 | Flongle 2 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debarcoded readsa | Deindexed readsb | Viral reads | Debarcoded readsa | Deindexed readsb | Viral reads | Debarcoded readsa | Deindexed readsb | Viral reads | |||||||||||||
| YFV | DENV1 | DENV2 | Other Flaviviruses | Other Virus | YFV | DENV1 | DENV2 | Other Flaviviruses | Other Virus | YFV | DENV1 | DENV2 | Other Flaviviruses | Other Virus | |||||||
| DENV1 | 2960 | 684 | 0 | 607 | 0 | 0 | 0 | 1669 | 447 | 0 | 408 | 0 | 0 | 0 | 6632 | 2291 | 0 | 1872 | 0 | 0 | 0 |
| DENV2 | 5062 | 1454 | 0 | 0 | 1055 | 2 | 0 | 1254 | 182 | 0 | 0 | 151 | 0 | 0 | 5243 | 1711 | 0 | 0 | 1187 | 0 | 0 |
| YFV | 3066 | 397 | 350 | 0 | 0 | 0 | 0 | 964 | 362 | 329 | 0 | 0 | 0 | 0 | 3970 | 1085 | 943 | 3 | 4 | 0 | 0 |
| DENV1 | 5312 | 2068 | 0 | 1784 | 0 | 0 | 0 | 1237 | 312 | 0 | 276 | 0 | 0 | 0 | 5563 | 709 | 0 | 573 | 0 | 0 | 0 |
| DENV2 | 2541 | 271 | 0 | 0 | 203 | 0 | 0 | 676 | 483 | 0 | 0 | 400 | 1 | 0 | 2384 | 737 | 0 | 0 | 515 | 1 | 0 |
| YFV | 5942 | 1988 | 1754 | 0 | 0 | 0 | 0 | 1184 | 272 | 254 | 0 | 0 | 0 | 0 | 687 | 155 | 134 | 0 | 0 | 0 | 0 |
| DENV1 | 1583 | 306 | 0 | 266 | 0 | 0 | 0 | 607 | 210 | 0 | 190 | 0 | 0 | 0 | 4163 | 1666 | 0 | 1388 | 0 | 0 | 0 |
| DENV2 | 1796 | 498 | 0 | 0 | 353 | 0 | 0 | 2304 | 91 | 0 | 0 | 70 | 0 | 0 | 8422 | 3254 | 0 | 1 | 2251 | 2 | 0 |
| YFV | 1978 | 506 | 457 | 0 | 0 | 0 | 0 | 1431 | 371 | 338 | 0 | 0 | 0 | 0 | 3630 | 845 | 751 | 0 | 0 | 0 | 0 |
| DENV1 | 2382 | 541 | 0 | 492 | 0 | 0 | 0 | 993 | 459 | 0 | 401 | 0 | 0 | 0 | 5323 | 1790 | 0 | 1555 | 0 | 0 | 0 |
| DENV2 | 4183 | 533 | 0 | 0 | 410 | 2 | 0 | 1051 | 809 | 0 | 0 | 618 | 4 | 0 | 7288 | 2045 | 0 | 1 | 1400 | 2 | 0 |
| YFV | 3253 | 456 | 403 | 0 | 0 | 0 | 0 | 1010 | 273 | 243 | 0 | 0 | 0 | 0 | 2613 | 791 | 0 | 3 | 0 | 0 | |
Viral RNA was extracted from fetal bovine serum spiked with 105 PFU/mL DENV1, 104 PFU/mL DENV2, and 105 PFU/mL YFV17D, then subjected to RT-PCR and sequencing. The number of reads shown in the table were obtained the optimized pipeline data was analysed according to the pipeline shown in the Supplementary Fig. 1
aReads survived after the debarcoded step is referred to debarcoded reads.
bWhile reads passing the deindexing step will be referred as deindexed reads.
Data of the positive results for RT-PCR and sequencing obtained from clinical samples in Vietnam.
| Index | Day of fever | NS1a | bCt Value (qPCR) | RT-PCRc | Flongle | Minion | dNumber of reads | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DENV1 | DENV2 | DENV3 | DENV4 | Other flaviviruses | Other viruses | |||||||
| i01-i20 | 4 | + | − | + | DENV2 | Not tested | 3 | 44 | 0 | 0 | 0 | 0 |
| i03-i15 | 6 | + | − | − | − | DENV1 | 12 | 0 | 0 | 0 | 0 | 0 |
| i06-i15 | 2 | + | − | − | − | DENV4 | 0 | 0 | 0 | 16 | 0 | 0 |
| i06-i18 | 3 | + | 39 | − | − | − | 0 | 0 | 0 | 0 | 0 | 0 |
| i06-i19 | 1 | + | 28.2 | + | DENV1 | Not tested | 179 | 0 | 0 | 0 | 0 | 0 |
| i06-i20 | 4 | + | 41.5 | − | − | DENV1 | 187 | 0 | 0 | 0 | 0 | 0 |
| i06-i21 | 2 | + | 35.8 | − | − | − | 0 | 0 | 0 | 0 | 0 | 0 |
| i06-i22 | 3 | + | 34 | − | − | DENV1 | 107 | 0 | 0 | 0 | 0 | 0 |
| i06-i23 | 2 | + | 32.5 | + | DENV1 | Not tested | 43 | 0 | 0 | 0 | 0 | 0 |
| i08-i20 | 1 | − | Not tested | − | DENV1 | 60 | 0 | 0 | 0 | 0 | 0 | |
Viral RNA was extracted from 114 serum sample, then subjected to pan-flavivirus RT-PCR and sequencing. First-round of sequencing was carried out using a Flongle flowcell. Positive samples were then excluded from the second-round sequencing (using a MinION flowcell).
aAs a comparison, the samples were also screened with the NS1 antigen test.
bSamples positive for NS1 were also subjected to the CDC based DENV-1-4 Real-Time RT-PCR Multiplex Assay.
cPrior to sequencing, 1 µL of PCR product were visualized on agarose, alongside 100 bp DNA ladder (Supplementary Fig. S5).
dReads meeting the criteria were counted at the end of analysis and presented here.
Sensitivity and specificity of clinical result.
| Comparative assay | Test | Sensitivity (positive agreement) (%) | Specificity (negative agreement) (%) |
|---|---|---|---|
| NS1 | gel | 4.23 | 100.00 |
| NS1 | Flongle | 4.23 | 100.00 |
| NS1 | Nanopore | 9.86 | 97.67 |
| RT-qPCR | Flongle | 33.33 | 98.46 |
| RT-qPCR | Nanopore | 66.67 | 95.38 |
| Flongle | RT-qPCR | 66.67 | 94.12 |
| Nanopore | RT-qPCR | 57.14 | 96.88 |